67 related articles for article (PubMed ID: 21535451)
21. Achieving Resilience in Aging: How Mitochondrial Modulation Drives Age-associated Fluconazole Tolerance in
Yoo K; Oliveira NK; Bhattacharya S; Fries BC
bioRxiv; 2024 Mar; ():. PubMed ID: 38585804
[TBL] [Abstract][Full Text] [Related]
22. Early clinical and microbiological predictors of outcome in hospitalized patients with cryptococcal meningitis.
de Oliveira L; Melhem MSC; Buccheri R; Chagas OJ; Vidal JE; Diaz-Quijano FA
BMC Infect Dis; 2022 Feb; 22(1):138. PubMed ID: 35139801
[TBL] [Abstract][Full Text] [Related]
23. ATI-2307 Exhibits Equivalent Antifungal Activity in
Gerlach ES; Altamirano S; Yoder JM; Luggya TS; Akampurira A; Meya DB; Boulware DR; Rhein J; Nielsen K
Front Cell Infect Microbiol; 2021; 11():695240. PubMed ID: 34249782
[TBL] [Abstract][Full Text] [Related]
24. Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017.
Fang LF; Zhang PP; Wang J; Yang Q; Qu TT
Braz J Infect Dis; 2020; 24(1):7-12. PubMed ID: 31870760
[TBL] [Abstract][Full Text] [Related]
25. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model.
Chesdachai S; Rajasingham R; Nicol MR; Meya DB; Bongomin F; Abassi M; Skipper C; Kwizera R; Rhein J; Boulware DR
Open Forum Infect Dis; 2019 Oct; 6(10):. PubMed ID: 31420668
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
Lofgren S; Abassi M; Rhein J; Boulware DR
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):331-340. PubMed ID: 28111998
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin.
Fuchs BB; RajaMuthiah R; Souza AC; Eatemadpour S; Rossoni RD; Santos DA; Junqueira JC; Rice LB; Mylonakis E
Future Med Chem; 2016; 8(2):117-32. PubMed ID: 26808006
[TBL] [Abstract][Full Text] [Related]
28. Cryptococcal Meningitis: Diagnosis and Management Update.
Abassi M; Boulware DR; Rhein J
Curr Trop Med Rep; 2015 Jun; 2(2):90-99. PubMed ID: 26279970
[TBL] [Abstract][Full Text] [Related]
29. Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011.
Lizarazo J; Escandón P; Agudelo CI; Firacative C; Meyer W; Castañeda E
PLoS Negl Trop Dis; 2014; 8(11):e3272. PubMed ID: 25411779
[TBL] [Abstract][Full Text] [Related]
30. New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.
Jackson A; van der Horst C
Curr HIV/AIDS Rep; 2012 Sep; 9(3):267-77. PubMed ID: 22763808
[TBL] [Abstract][Full Text] [Related]
31. Physiological Differences in Cryptococcus neoformans Strains
Grossman NT; Casadevall A
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031206
[No Abstract] [Full Text] [Related]
32. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
33. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya.
Mdodo R; Moser SA; Jaoko W; Baddley J; Pappas P; Kempf MC; Aban I; Odera S; Jolly P
Mycoses; 2011 Sep; 54(5):e438-42. PubMed ID: 21535451
[TBL] [Abstract][Full Text] [Related]
34. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya.
Bii CC; Makimura K; Abe S; Taguchi H; Mugasia OM; Revathi G; Wamae NC; Kamiya S
Mycoses; 2007 Jan; 50(1):25-30. PubMed ID: 17302744
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans.
Tewari A; Behera B; Mathur P; Xess I
Mycopathologia; 2012 Jun; 173(5-6):427-33. PubMed ID: 22354778
[TBL] [Abstract][Full Text] [Related]
36. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.
Bertout S; Drakulovski P; Kouanfack C; Krasteva D; Ngouana T; Dunyach-Rémy C; Dongtsa J; Aghokeng A; Delaporte E; Koulla-Shiro S; Reynes J; Mallié M
Clin Microbiol Infect; 2013 Aug; 19(8):763-9. PubMed ID: 23033854
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
